Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention

Abraham, 2010, J Am Coll Cardiol, 56, 2051, 10.1016/j.jacc.2010.09.010 Bhatt, 2010, Clopidogrel with or without omeprazole in coronary heart disease, N Engl J Med, 363, 1909, 10.1056/NEJMoa1007964 Bhatt, 2008, ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents, Circulation, 118, 1894, 10.1161/CIRCULATIONAHA.108.191087 Blume, 2006, Pharmacokinetic drug interaction profiles of proton pump inhibitors, Drug Saf, 29, 769, 10.2165/00002018-200629090-00002 Chow, 2009, Is it safe to use a proton pump inhibitor with clopidogrel?, Pol Arch Int Med, 119, 564 Cuisset, 2009, Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study, J Am Coll Cardiol, 54, 1149, 10.1016/j.jacc.2009.05.050 Engelhardt, 2010, Pantoprazole does not influence the antiplatelet effect of clopidogrel – A whole blood aggregometry study following coronary stenting, J Cardiovasc Pharmacol, 56, 91, 10.1097/FJC.0b013e3181e19739 Evanchan, 2010, Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction, Clin Cardiol, 33, 168, 10.1002/clc.20721 Fox, 2006, Guidelines on the management of stable angina pectoris: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology, Eur Heart J, 27, 1341, 10.1093/eurheartj/ehl001 Gilard, 2008, Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin, J Am Coll Cardiol, 51, 256, 10.1016/j.jacc.2007.06.064 Gilard, 2006, Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin, J Thromb Haemost, 4, 2508, 10.1111/j.1538-7836.2006.02162.x Gremmel, 2010, Is TRAP-6 suitable as a positive control for platelet reactivity when assessing response to clopidogrel?, Platelets, 21, 515, 10.3109/09537104.2010.493587 Guthikonda, 2008, Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease, J Am Coll Cardiol, 52, 743, 10.1016/j.jacc.2008.05.031 Hochholzer, 2010, Impact of cyto-chrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement, J Am Coll Cardiol, 55, 2427, 10.1016/j.jacc.2010.02.031 Horn, 2003, Do statins inhibit clopidogrel’s antipletelet activity?, Pharm Times, 10, 1 Kushner, 2009, ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction, Circulation, 120, 2271, 10.1161/CIRCULATIONAHA.109.192663 Kwok, 2010, Meta-analysis: The effects of PPIs on CV events and mortality in patients receiving clopidogrel, Aliment Pharmacol Ther, 31, 810 Lau, 2004, Contribution of hepatic P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance, Circulation, 109, 166, 10.1161/01.CIR.0000112378.09325.F9 Li, 2004, Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole and rabeprazole on human cytochrome P450 activities, Drug Metab Dispos, 32, 821, 10.1124/dmd.32.8.821 Mega, 2009, Cytochrome P-450 polymorphisms and response to clopidogrel, N Engl J Med, 360, 354, 10.1056/NEJMoa0809171 Nguyen, 2006, Variability of response to clopidogrel: possible mechanisms and clinical implications, Cardiol Rev, 14, 136, 10.1097/01.crd.0000188033.11188.8e O’Donoghue, 2009, Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials, Lancet, 374, 989, 10.1016/S0140-6736(09)61525-7 Price, 2009, Predictors of heightened platelet reactivity despite dual antiplatelet therapy in patients undergoing percutaneous coronary intervention, Am J Cardiol, 103, 1339, 10.1016/j.amjcard.2009.01.341 Robier, 2010, Evaluation of platelet function and pharmacological platelet inhibition in patients with myeloproliferative disorders using multiple electrode aggregometry, Thromb Res, 126, 232, 10.1016/j.thromres.2010.06.014 Shoa-Lin, 2011, Clinical evidence of interaction between clopidogrel and proton pump inhibitors, World J Cardiol, 3, 153, 10.4330/wjc.v3.i5.153 Sibbing, 2009, Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel, Thromb Haemost, 101, 714, 10.1160/TH08-12-0808 Siller-Matula, 2009, Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel, Am Heart J, 157, 148e1, 10.1016/j.ahj.2008.09.017 Stedman, 2000, Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors, Aliment Pharmacol Ther, 12, 963, 10.1046/j.1365-2036.2000.00788.x Stockl, 2010, Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor, Arch Intern Med, 170, 704, 10.1001/archinternmed.2010.34 Van der Stelt, 2007, To adjust or not to adjust the platelet count in light transmission aggregometry in patients receiving dual aspirin/clopidogrel treatment, Platelets, 18, 550, 10.1080/09537100701326721